Alexion Pharmaceuticals Inc. (ALXN) News Nov 18, 2
Post# of 250665
Posted On: 11/18/2014 9:36:19 PM
Alexion Pharmaceuticals Inc. (ALXN) News Nov 18, 2014, 6:50 p.m.
MarketWatch News on ALXN
Are consumers getting gouged on health care? 12:59 p.m. Today - Russ Britt
Alexion Pharmaceuticals shares advance 5.3% 8:32 a.m. Oct. 23, 2014 - Sue Chang
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 3:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 10:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 2:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 3:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 8:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 2:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 5:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 3:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 3:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 4:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 3:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 1:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 11:48 a.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 3:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 3:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 3:16 p.m. March 21, 2014 - Sue Chang
Loading more headlines...
Advertisement
Other News on ALXN
Why Celldex Therapeutics' Stock Is Now Ready For Takeoff 2:44 p.m. Today - Seeking Alpha
Here Are Some Big Caps Poised To Make Gains 5:45 p.m. Nov. 17, 2014 - Investors Business Daily
Gilead Has Been Rocked After Earnings, But I'm Looking To Buy! 12:35 p.m. Nov. 17, 2014 - Seeking Alpha
Stock Market News for November 17, 2014 - Market News 10:10 a.m. Nov. 17, 2014 - Zacks.com
Medical Stocks Tumble But Most Of IBD 50 Trading Well 5:47 p.m. Nov. 14, 2014 - Investors Business Daily
Eye Best Mutual Funds Like Magellan For Great Stocks 4:50 p.m. Nov. 14, 2014 - Investors Business Daily
Alexion, EA: Two Top Stocks Form Good Chart Patterns 3:51 p.m. Nov. 14, 2014 - Investors Business Daily
Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining 7:59 a.m. Nov. 13, 2014 - Seeking Alpha
Meet 5 U.S. Techs, Biotechs With Strong Fundamentals 7:02 a.m. Nov. 13, 2014 - Investors Business Daily
10 Must-Own Stocks With Great Earnings, Sales and Guidance 12:15 a.m. Nov. 13, 2014 - InvestorPlace.com
Biotech Short Interest Becomes Stock Specific 8:11 a.m. Nov. 12, 2014 - 247WallSt.com
Earnings Triple Plays 2:54 a.m. Nov. 12, 2014 - Seeking Alpha
Big Cap 20 Stuffed With Medical Names 6:34 p.m. Nov. 10, 2014 - Investors Business Daily
Big Cap 20 Stuffed With Medical Names 6:34 p.m. Nov. 10, 2014 - Investors Business Daily
Sarepta Q3 Loss Narrower-Than-Expected, Eteplirsen in Focus - Analyst Blog 12:40 p.m. Nov. 10, 2014 - Zacks.com
Hottest Healthcare Stocks Now – GHDX PODD NPSP ALXN 12:00 p.m. Nov. 7, 2014 - InvestorPlace.com
Why Alexion Is A Buy 8:41 a.m. Nov. 5, 2014 - Seeking Alpha
These 5 Drugmakers' Earnings Excelled This Quarter 7:14 p.m. Nov. 4, 2014 - Investors Business Daily
Top Funds Buy Ulta Beauty, Alexion, Avago 5:52 p.m. Nov. 4, 2014 - Investors Business Daily
Why Alexion Pharmaceuticals (ALXN) Could Be an Impressive Growth Stock - Tale of the Tape 8:37 a.m. Nov. 4, 2014 - Zacks.com
Loading more headlines...
Press Releases on ALXN
Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment 10:00 a.m. Nov. 15, 2014 - BusinessWire - BZX
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015 6:30 a.m. Nov. 10, 2014 - BusinessWire - BZX
Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting 4:16 p.m. Nov. 6, 2014 - BusinessWire - BZX
Neurotrope Appoints Warren W. Wasiewski, M.D. as Executive Vice President, Development and Chief Medical Officer 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Alexion Launches Every Day with HPP™ Campaign in Support of Hypophosphatasia (HPP) Awareness Week 4:51 p.m. Oct. 27, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 9:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
Researchers to Present Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS at ASN 2014 Annual Meeting 4:15 p.m. Oct. 23, 2014 - BusinessWire - BZX
Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion 9:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Critical Alerts For Sears Holdings, JetBlue, Qlogic, Las Vegas Sands and Alexion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 15, 2014 - PR Newswire - PRF
Alexion Submits NDA in Japan for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:30 a.m. Oct. 15, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Third Quarter 2014 Results on Thursday, October 23, 2014 10:00 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Board of Directors Appoints New Chairman and Creates the New Position of Lead Independent Director 6:30 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company’s Board of Directors 4:00 p.m. Oct. 7, 2014 - BusinessWire - BZX
WuXi PharmaTech Announces Appointment of William R. Keller to Board 8:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
Acquisitions, Senior Level Promotions, Public Offering, and Drug Approvals - Research Reports on Acorda, Alexion, Envision, Lilly and Avanir 8:50 a.m. Sept. 29, 2014 - PR Newswire - PRF
Paediatric Patients with Hypophosphatasia Receiving Investigational Asfotase Alfa Had Sustained Improvements in Growth and Physical Function 4:49 a.m. Sept. 19, 2014 - BusinessWire - BZX
Alexion Strengthens and Broadens Its Executive Leadership Team 7:30 a.m. Sept. 17, 2014 - BusinessWire - BZX
Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years 5:30 p.m. Sept. 14, 2014 - BusinessWire - BZX
NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England 7:01 p.m. Sept. 3, 2014 - BusinessWire - BZX
Loading more headlines...
MarketWatch News on ALXN
Are consumers getting gouged on health care? 12:59 p.m. Today - Russ Britt
Alexion Pharmaceuticals shares advance 5.3% 8:32 a.m. Oct. 23, 2014 - Sue Chang
Bed Bath, Starz gain; Citizens Financial debuts 2:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 3:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 10:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 2:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 3:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 8:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 2:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 5:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 3:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 3:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 12:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 4:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 3:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 1:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 11:48 a.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 3:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 3:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 3:16 p.m. March 21, 2014 - Sue Chang
Loading more headlines...
Advertisement
Other News on ALXN
Why Celldex Therapeutics' Stock Is Now Ready For Takeoff 2:44 p.m. Today - Seeking Alpha
Here Are Some Big Caps Poised To Make Gains 5:45 p.m. Nov. 17, 2014 - Investors Business Daily
Gilead Has Been Rocked After Earnings, But I'm Looking To Buy! 12:35 p.m. Nov. 17, 2014 - Seeking Alpha
Stock Market News for November 17, 2014 - Market News 10:10 a.m. Nov. 17, 2014 - Zacks.com
Medical Stocks Tumble But Most Of IBD 50 Trading Well 5:47 p.m. Nov. 14, 2014 - Investors Business Daily
Eye Best Mutual Funds Like Magellan For Great Stocks 4:50 p.m. Nov. 14, 2014 - Investors Business Daily
Alexion, EA: Two Top Stocks Form Good Chart Patterns 3:51 p.m. Nov. 14, 2014 - Investors Business Daily
Molecular Biology Meets Finance: MLV's George Zavoico On Ebola's Silver Lining 7:59 a.m. Nov. 13, 2014 - Seeking Alpha
Meet 5 U.S. Techs, Biotechs With Strong Fundamentals 7:02 a.m. Nov. 13, 2014 - Investors Business Daily
10 Must-Own Stocks With Great Earnings, Sales and Guidance 12:15 a.m. Nov. 13, 2014 - InvestorPlace.com
Biotech Short Interest Becomes Stock Specific 8:11 a.m. Nov. 12, 2014 - 247WallSt.com
Earnings Triple Plays 2:54 a.m. Nov. 12, 2014 - Seeking Alpha
Big Cap 20 Stuffed With Medical Names 6:34 p.m. Nov. 10, 2014 - Investors Business Daily
Big Cap 20 Stuffed With Medical Names 6:34 p.m. Nov. 10, 2014 - Investors Business Daily
Sarepta Q3 Loss Narrower-Than-Expected, Eteplirsen in Focus - Analyst Blog 12:40 p.m. Nov. 10, 2014 - Zacks.com
Hottest Healthcare Stocks Now – GHDX PODD NPSP ALXN 12:00 p.m. Nov. 7, 2014 - InvestorPlace.com
Why Alexion Is A Buy 8:41 a.m. Nov. 5, 2014 - Seeking Alpha
These 5 Drugmakers' Earnings Excelled This Quarter 7:14 p.m. Nov. 4, 2014 - Investors Business Daily
Top Funds Buy Ulta Beauty, Alexion, Avago 5:52 p.m. Nov. 4, 2014 - Investors Business Daily
Why Alexion Pharmaceuticals (ALXN) Could Be an Impressive Growth Stock - Tale of the Tape 8:37 a.m. Nov. 4, 2014 - Zacks.com
Loading more headlines...
Press Releases on ALXN
Longer-term Outcome Data from the Largest Prospective Trial of Soliris® (eculizumab) in aHUS Underscore the Effectiveness of Ongoing Soliris Treatment 10:00 a.m. Nov. 15, 2014 - BusinessWire - BZX
Alexion Announces Planned Retirement of Stephen Squinto, Ph.D., Company Co-Founder and Chief Global Operations Officer, in January 2015 6:30 a.m. Nov. 10, 2014 - BusinessWire - BZX
Researchers to Present Data on Improving the Understanding of PNH and aHUS and Underscoring the Effectiveness of Soliris® (eculizumab) Treatment at ASH 2014 Annual Meeting 4:16 p.m. Nov. 6, 2014 - BusinessWire - BZX
Neurotrope Appoints Warren W. Wasiewski, M.D. as Executive Vice President, Development and Chief Medical Officer 8:30 a.m. Nov. 6, 2014 - PR Newswire - PRF
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Alexion Launches Every Day with HPP™ Campaign in Support of Hypophosphatasia (HPP) Awareness Week 4:51 p.m. Oct. 27, 2014 - BusinessWire - BZX
Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 9:00 a.m. Oct. 24, 2014 - PR Newswire - PRF
Researchers to Present Data on Soliris® (eculizumab) as a Treatment for Patients with aHUS at ASN 2014 Annual Meeting 4:15 p.m. Oct. 23, 2014 - BusinessWire - BZX
Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion 9:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Critical Alerts For Sears Holdings, JetBlue, Qlogic, Las Vegas Sands and Alexion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 15, 2014 - PR Newswire - PRF
Alexion Submits NDA in Japan for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:30 a.m. Oct. 15, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Third Quarter 2014 Results on Thursday, October 23, 2014 10:00 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Board of Directors Appoints New Chairman and Creates the New Position of Lead Independent Director 6:30 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company’s Board of Directors 4:00 p.m. Oct. 7, 2014 - BusinessWire - BZX
WuXi PharmaTech Announces Appointment of William R. Keller to Board 8:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
Acquisitions, Senior Level Promotions, Public Offering, and Drug Approvals - Research Reports on Acorda, Alexion, Envision, Lilly and Avanir 8:50 a.m. Sept. 29, 2014 - PR Newswire - PRF
Paediatric Patients with Hypophosphatasia Receiving Investigational Asfotase Alfa Had Sustained Improvements in Growth and Physical Function 4:49 a.m. Sept. 19, 2014 - BusinessWire - BZX
Alexion Strengthens and Broadens Its Executive Leadership Team 7:30 a.m. Sept. 17, 2014 - BusinessWire - BZX
Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years 5:30 p.m. Sept. 14, 2014 - BusinessWire - BZX
NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England 7:01 p.m. Sept. 3, 2014 - BusinessWire - BZX
Loading more headlines...
(0)
(0)